Creo Medical Group PLC (CREO) — Net Asset Quality Index
Creo Medical Group PLC (CREO) has a Net Asset Quality Index of 88.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX68.80 Million minus total liabilities of GBX7.90 Million yields net assets of GBX60.90 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Creo Medical Group PLC asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Creo Medical Group PLC Net Asset Quality Index Over Time (2005–2024)
This chart shows how Creo Medical Group PLC's Net Asset Quality Index has evolved across 17 annual periods from 2005 to 2024. As of June 2025, the index stands at 88.5%, representing net assets of GBX60.90 Million against total assets of GBX68.80 Million GBX. See CREO working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Creo Medical Group PLC (2005–2024)
The table below presents the year-by-year Net Asset Quality Index for Creo Medical Group PLC from 2005 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Creo Medical Group PLC stock valuation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 65.2% | GBX42.40 Million | GBX65.00 Million | GBX22.60 Million | ▼ -12.8 pp |
| 2023 | 78.1% | GBX59.80 Million | GBX76.60 Million | GBX16.80 Million | ▲ +12.5 pp |
| 2022 | 65.6% | GBX49.40 Million | GBX75.34 Million | GBX25.93 Million | ▼ -7.3 pp |
| 2021 | 72.9% | GBX73.32 Million | GBX100.61 Million | GBX27.29 Million | ▲ +4.9 pp |
| 2020 | 67.9% | GBX62.81 Million | GBX92.46 Million | GBX29.66 Million | ▼ -25.7 pp |
| 2019 | 93.7% | GBX82.66 Million | GBX88.26 Million | GBX5.60 Million | ▼ -2.3 pp |
| 2018 | 95.9% | GBX47.71 Million | GBX49.75 Million | GBX2.03 Million | ▲ +19.7 pp |
| 2018 | 76.2% | GBX7.33 Million | GBX9.62 Million | GBX2.29 Million | ▼ -14.7 pp |
| 2017 | 90.9% | GBX14.65 Million | GBX16.12 Million | GBX1.47 Million | ▲ +23.5 pp |
| 2016 | 67.4% | GBX1.63 Million | GBX2.42 Million | GBX788.81K | ▼ -18.4 pp |
| 2016 | 85.8% | GBX3.22 Million | GBX3.75 Million | GBX532.79K | ▲ +14.2 pp |
| 2015 | 71.7% | GBX748.41K | GBX1.04 Million | GBX295.98K | ▼ -12.9 pp |
| 2014 | 84.6% | GBX1.37 Million | GBX1.62 Million | GBX250.20K | ▲ +18.5 pp |
| 2008 | 66.1% | GBX113.00K | GBX171.00K | GBX58.00K | ▲ +61.4 pp |
| 2007 | 4.7% | GBX12.00K | GBX257.00K | GBX245.00K | ▲ +6.5 pp |
| 2006 | -1.9% | GBX-3.00K | GBX161.00K | GBX164.00K | ▲ +238.1 pp |
| 2005 | -240.0% | GBX-12.00K | GBX5.00K | GBX17.00K | — |